fingolimod hydrochloride has been researched along with Anoxemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali Mard, S; Farbood, Y; Ghafouri, S; Hajipour, S; Khombi Shooshtari, M; Moradi Chameh, H; Sarkaki, A; Sistani Karampour, N | 1 |
| Farbood, Y; Ghafouri, S; Najafian, SA; Sarkaki, A | 1 |
| Brede, M; Deppermann, C; Göb, E; Göbel, K; Herrmann, AM; Kleinschnitz, C; Kraft, P; Lorenz, K; Meuth, SG; Nieswandt, B; Pfeilschifter, W; Schuhmann, MK; Stoll, G; Thielmann, I | 1 |
| Ader, I; Cuvillier, O; Gstalder, C | 1 |
| Botchwey, EA; Bowers, DT; Brayman, KL; Chhabra, P; Langman, L | 1 |
5 other study(ies) available for fingolimod hydrochloride and Anoxemia
| Article | Year |
|---|---|
Fingolimod Administration Following Hypoxia Induced Neonatal Seizure Can Restore Impaired Long-term Potentiation and Memory Performance in Adult Rats.
Topics: Animals; Epilepsy; Female; Fingolimod Hydrochloride; gamma-Aminobutyric Acid; Hippocampus; Hypoxia; Long-Term Potentiation; Male; Memory Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Seizures | 2023 |
FTY720 administration following hypoxia-induced neonatal seizure reverse cognitive impairments and severity of seizures in male and female adult rats: The role of inflammation.
Topics: Aging; Animals; Animals, Newborn; Cognitive Dysfunction; Epilepsy; Female; Fingolimod Hydrochloride; Hippocampus; Hypoxia; Inflammation; Male; Neuroprotective Agents; Pentylenetetrazole; Rats; Seizures; Severity of Illness Index | 2021 |
FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
Topics: Animals; Brain Ischemia; Enzyme Inhibitors; Fingolimod Hydrochloride; Homeodomain Proteins; Hypoxia; Immunosuppressive Agents; Inflammation; Lymphocytes; Lymphopenia; Male; Mice; Mice, Transgenic; Middle Cerebral Artery; Neurons; Neuroprotective Agents; Propylene Glycols; Sphingosine; Stroke; Thrombosis | 2013 |
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fingolimod Hydrochloride; Gene Expression; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Mice; Neovascularization, Pathologic; Oxygen Consumption; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Vascular Endothelial Growth Factor A; Vascular Remodeling; Xenograft Model Antitumor Assays | 2016 |
FTY720-loaded poly(DL-lactide-co-glycolide) electrospun scaffold significantly increases microvessel density over 7 days in streptozotocin-induced diabetic C57b16/J mice: preliminary results.
Topics: Animals; Automation; Biocompatible Materials; Diabetes Mellitus, Experimental; Drug Delivery Systems; Extracellular Matrix; Fingolimod Hydrochloride; Hypoxia; Image Processing, Computer-Assisted; Immunosuppressive Agents; Lactic Acid; Male; Materials Testing; Mice; Mice, Inbred C57BL; Microvessels; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Propylene Glycols; Sphingosine; Streptozocin; Tissue Scaffolds | 2011 |